152 related articles for article (PubMed ID: 7878597)
1. [Controlled randomized trials of pharmaceutic aids for smoking cessation. Results and perspectives].
Said S; Berlin I; Puech AJ
Therapie; 1994; 49(4):313-9. PubMed ID: 7878597
[TBL] [Abstract][Full Text] [Related]
2. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
Rose JE; Herskovic JE; Behm FM; Westman EC
Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
4. Smoking behavior on the first day of a quit attempt predicts long-term abstinence.
Westman EC; Behm FM; Simel DL; Rose JE
Arch Intern Med; 1997 Feb; 157(3):335-40. PubMed ID: 9040302
[TBL] [Abstract][Full Text] [Related]
5. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
Becker KM; Rose JE; Albino AP
Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
[TBL] [Abstract][Full Text] [Related]
7. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
[TBL] [Abstract][Full Text] [Related]
8. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
Schneider MP; van Melle G; Uldry C; Huynh-Ba M; Fallab Stubi CL; Iorillo D; Burnier M; Zellweger JP
Nicotine Tob Res; 2003 Oct; 5(5):719-27. PubMed ID: 14577988
[TBL] [Abstract][Full Text] [Related]
9. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Yudkin PL; Jones L; Lancaster T; Fowler GH
Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
[TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
11. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
12. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
[TBL] [Abstract][Full Text] [Related]
13. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
Foulds J
Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Florek E; Piekoszewski W
Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
Wasley MA; McNagny SE; Phillips VL; Ahluwalia JS
Prev Med; 1997; 26(2):264-70. PubMed ID: 9085397
[TBL] [Abstract][Full Text] [Related]
16. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.
Le Houezec J
Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation interventions in clinical practice.
Cornuz J
Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
[TBL] [Abstract][Full Text] [Related]
18. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
19. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user.
Hajek P; McRobbie H; Gillison F
Prev Med; 2007 Mar; 44(3):230-4. PubMed ID: 17207524
[TBL] [Abstract][Full Text] [Related]
20. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
